Hannah Phelps Presentation
Elyse Everett
Created on August 31, 2024
More creations to inspire you
THE MESOZOIC ERA
Presentation
GROWTH MINDSET
Presentation
VISUAL COMMUNICATION AND STORYTELLING
Presentation
ASTL
Presentation
TOM DOLAN
Presentation
BASIL RESTAURANT PRESENTATION
Presentation
AC/DC
Presentation
Transcript
Hannah Phelps MSNMT R.T.(R)(N), ARRT
y90 Radioembolization therapy
risks and benefits of procedure
Steps of Drawing the dose
Pre-Procedure mapping
Isotope used
WHAT IS y90 RADIOEMBOLIZATION?
Index
- Also known as Selective Internal Radiation Therapy (SIRT)
- Delivers localized, high doses of radiation directly into a tumor's blood supply
- Emits radiation to slow the tumor's growth
- Palliative treatment
- Used to treat unresectable Hepatocellular Carcinoma (HCC) or secondary metastatic tumors of the liver
- Uses Yttrium 90 (Y90) radioactive beads (microspheres)
Y90 RADIOEMBOLIZATION
https://consultqd.clevelandclinic.org/liver-radioembolization-doubles-survival-time
https://nuclearsupplies.co.nz/products/sir-spheres%C2%AE-y-90-microspheres
Y90
- Half Life: 64.2 hrs or 2.67 days
- Beta radiation emmiter
- Two types of Y90 microspheres:
- Sir-SpheresR: biocompatible, resin based
- Thera-SpheresR: glass beads
Isotope Used For Therapy
Y90 Mapping
- Lung shunting study
- Performed prior to treatment
- Very similar process
- Radiologists will essentially map the blood flow to the tumor; often placing coils or embolizations as they go
- Deliberate to limit blood flow so that maximal dose goes to the desired location
- Tc99m MAA
- particulate
- similar in size to microspheres
- 4-5 mCi
- Images obtained:
- Ant/Post Lung statics
- Ant/Post Liver statics
- SPECT images of liver (if requested)
- ROI's are drawn and percentage of lung shunting is determined based on counts
Y90 Mapping Study
If >20% shunts to lungs, further embolization may be needed
Y90 Mapping Study
- Y90 dose
- Accessory pack
- V-Vial
- V-Vial holder
- Patient Delivery set
- Gloves
- Calculator
- Y90 dose worksheets
- Emesis basin
- Alcohol prep
- 25 ga needles (3)
- Micron filters (3)
- 3 ml syringe
- Sterile water
- Mayo jar
- Lucite shield
- Syringe shield
- Hemostats
- Survey Meter
Supplies Needed
- Place Micron filters on 25g needles
- Vent dose, sterile water & V-Vial
- Draw 2 opposing lines on top of V-Vial
Drawing the Dose
- Draw line at 3 ml on V-Vial
Drawing the Dose
- Shake dose for 30 seconds
- Measure and record dose
STOP! TIME FOR MATH
PLEASE REFER TO WORKSHEETS PROVIDED
- Inject dose into V-Vial
- Draw sterile water to reach desired volume (3ml)
- Shake dose for 30 seconds
- Remeasure and record dose
Drawing the Dose
- Insert 3ml syringe into center of dose and jet.
- Draw up desired volume.
- Use survey meter to measure radioactivity at 90 degree intervals
- Record findings
- Place V-Vial holder into mayo jar inside of lucite shield
Drawing the Dose
- Place stopper on top of V-Vial holder
https://www.sirtex.com/ap/products/sir-spheres-y-90-resin-microspheres/resources/
GUESS WHAT?MORE MATH!
PLEASE REFER TO WORKSHEETS PROVIDED
- Shows dispursment of Y90 microspheres in the liver
- Images obtained:
- Ant/Post Liver Statics
- SPECT Liver
- PET/CT may be requested depending on radiologist
Post Y90 Nuclear Imaging
Risks
- Infection
- Ulcers in stomach or duodenum
- Liver failure
- Secondary radiation effects in lungs
- Minimally invasive
- Fewer side effects
- Improves quality of life
- Can enable curative surgery or liver transplant
- Can be used in addition to other cancer treatments
- Radiation exposure to others is limited
Benefits
References
Wang, J., & Wu, C. (2018). Radioembolization with Yttrium-90: A review of its clinical applications and advances. Journal of Nuclear Medicine, 59(5), 727-736. Retrieved August 31, 2024, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840049/
Digirad. (n.d.). Y-90 therapy nuclear medicine information. Retrieved August 31, 2024, from https://www.digirad.com/y90-therapy-nuclear-medicine-information/
Eary, J. F., & Metcalf, R. A. (2014). Radioembolization for treatment of liver cancer. Journal of Nuclear Medicine, 55(3), 423-432. Retrieved August 31, 2024, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042917/
RadiologyInfo.org. (n.d.). Radioembolization. Retrieved August 31, 2024, from https://www.radiologyinfo.org/en/info/radioembol
Parker, D. S., & Burch, D. (2010). Dosimetry and clinical applications of radioembolization with Yttrium-90. Journal of Nuclear Medicine, 51(6), 869-880. Retrieved August 31, 2024, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036309/
Mayo Clinic Health System. (n.d.). Targeted radiation therapy. Retrieved August 31, 2024, from https://www.mayoclinichealthsystem.org/hometown-health/speaking-of-health/targeted- radiation-therapy
Sirtex. (n.d.). SIR-Spheres® Y-90 resin microspheres. Retrieved from https://sirtex.com
Global Medical Solutions NZ. (n.d.). SIR-Spheres® Y-90 Microspheres. Retrieved from Global Medical Solutions NZ
Cleveland Clinic. (April 15, 2014). Liver Radioembolization Doubles Survival Time. Retrieved from Cleveland Clinic Health Library